General Surgery Center, Chengdu Military General Hospital, China.
General Surgery Center, Chengdu Military General Hospital, China.
Pancreatology. 2018 Sep;18(6):635-641. doi: 10.1016/j.pan.2018.06.004. Epub 2018 Jun 18.
As the firs-line treatment for acute pancreatitis (AP) related infectious walled-off necrosis (WON), percutaneous catheter drainage (PCD) are usually accomplished under CT or US guidance, either of which has certain disadvantages. It is necessary to verify the clinical effects of using US and CT images fusion as guidance of PCD.
The total 94 consecutive AP patients with infected WON from January of 2013 to January of 2017 were included. Among these patients with infected WON, 48 received PCD under simple US guidance (US-PCD) and 46 under US/CT images fusion guidance (US/CT-PCD). The clinical data consisting of puncture data, drainage effectiveness indicators, intervention complications were collected.
The demographic characteristics and disease related characteristics of two groups were comparable. After 48 h of PCD treatment, the US/CT-PCD group achieved a significantly higher imaging effective rate, and significantly lower inflammatory response indexes and severity score, than the US-PCD group (P < 0.05). The US/CT-PCD group required fewer puncture times and drainage tubes and lower rate of advanced treatment, showing higher operational success rate than the US-PCD group (P < 0.05). Moreover, the US/CT-PCD group exhibited significantly fewer puncture related complications, lower hospital stay, intubation time, and hospitalization expenses than the US-PCD group (P < 0.05).
PCD treatment under the US/CT images fusion guidance is a reliable intervention with definite clinical effects for AP complicated with infected WON.
作为急性胰腺炎(AP)相关感染性包裹性坏死(WON)的一线治疗方法,经皮导管引流(PCD)通常在 CT 或 US 引导下进行,这两种方法都有一定的缺点。有必要验证使用 US 和 CT 图像融合作为 PCD 引导的临床效果。
共纳入 2013 年 1 月至 2017 年 1 月期间 94 例连续的 AP 合并感染性 WON 患者。在这些感染性 WON 患者中,48 例行单纯 US 引导下 PCD(US-PCD),46 例行 US/CT 图像融合引导下 PCD(US/CT-PCD)。收集穿刺数据、引流效果指标、介入并发症等临床资料。
两组患者的人口统计学特征和疾病相关特征无差异。PCD 治疗 48 小时后,US/CT-PCD 组的影像学有效率明显更高,炎症反应指标和严重程度评分明显更低(P<0.05)。US/CT-PCD 组需要的穿刺次数和引流管更少,升级治疗率更低,操作成功率高于 US-PCD 组(P<0.05)。此外,US/CT-PCD 组穿刺相关并发症发生率明显更低,住院时间、置管时间和住院费用明显更低(P<0.05)。
US/CT 图像融合引导下的 PCD 治疗是一种可靠的干预方法,对 AP 合并感染性 WON 具有明确的临床效果。